None listed
Conditions
Interventions
Others(Using the Pasta App) : All participants received standardized training from an obesity metabolic specialist at the start of the study and wore Continuous Glucose Monitoring for 2 weeks
after ra
Sponsors
Korea University Anam Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: During the target period, patients who receive anti-hormone treatment after completing breast surgery, chemotherapy, and radiation treatment for hormone receptor-positive early breast cancer at the hospital can be followed up as overweight or obese women with a BMI of = 23 (WHO Asian obesity standard), HbA1c <6.5% and can use the PASTA app and Continuous Glucose Monitoring
Exclusion criteria
Exclusion criteria: 1) Patients with recurrence or metastasis after breast cancer treatment 2) Weight change of 5% or more within the last 6 months 3) Those who have restrictions on the use of digital devices or apps 4) Diabetes mellitus patient 5) those who have used obesity medication (within 90 days from the screening visit) or with a history of bariatric surgery 6) those who are unable to wear Continuous Glucose Monitoring System due to skin problems, infections, or allergy to adhesives.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change in weight(percentage);5% and 10% weight loss achieved;systolic blood pressure changes;waist measurement | — |
Secondary
| Measure | Time frame |
|---|---|
| body weight;Body Mass Index;fasting blood sugar;diastolic blood pressure;Low density lipoprotein (LDL)- cholesterol ; C-reactive protein;muscle mass;change in body fat mass;High density lipoprotein (HDL)- cholesterol | — |
Countries
Korea, Republic of
Contacts
Public ContactGyu Bae Lee
Korea University Anam Hospital
Outcome results
None listed